These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 878840)

  • 21. The stability and reliability of radioimmunoassays for clonazepam, diphenylhydantoin and phenobarbital in blood, serum or plasma.
    Spiegel HE; Symington J; Savulich A
    Res Commun Chem Pathol Pharmacol; 1978 Feb; 19(2):271-80. PubMed ID: 644122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum level of phenobarbital or/and diphenylhydantoin in epileptics with some preexisting serum lipid alterations. Correlations with the treatment efficiency in epilepsy.
    Rogozea R; Florea-Ciocoiu V; Balaita C; Luca N
    Acta Neurol Belg; 1981; 81(1):24-32. PubMed ID: 7223355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of anticonvulsant drugs which induce liver microsomal enzymes on derived and ingested phenobarbitone levels.
    Callaghan N; Feely M; Duggan F; O'Callaghan M; Seldrup J
    Acta Neurol Scand; 1977 Jul; 56(1):1-6. PubMed ID: 878841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of dextropropoxyphene on steady state serum levels and protein binding of three anti-epileptic drugs in man.
    Hansen BS; Dam M; Brandt J; Hvidberg EF; Angelo H; Christensen JM; Lous P
    Acta Neurol Scand; 1980 Jun; 61(6):357-67. PubMed ID: 6998251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The necessity of drug level monitoring in anticonvulsant drug therapy.
    Davis HL; Bailey DG; Johnson GE; Wilson TW
    Can J Physiol Pharmacol; 1976 Dec; 54(6):850-8. PubMed ID: 1021220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute anticonvulsant effects of diphenylhydantoin, phenobarbital, and carbamazepine: a combined electroclinical and serum level study in amygdaloid kindled cats and baboons.
    Wada JA; Osawa T; Sato M; Wake A; Corcoran ME; Troupin AS
    Epilepsia; 1976 Mar; 17(1):77-88. PubMed ID: 817895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosing accuracy of antiepileptic drug regimens as determined by serum concentrations in outpatient epilepsy clinic patients.
    Privitera MD
    Ther Drug Monit; 1989 Nov; 11(6):647-51. PubMed ID: 2595745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonazepam: its efficacy in association with phenytoin and phenobarbital in mental patients with generalized major motor seizures.
    Bielmann P; Levac T; Gagnon MA
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):268-73. PubMed ID: 352972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development, validation and clinical application of an online-SPE-LC-HRMS/MS for simultaneous quantification of phenobarbital, phenytoin, carbamazepine, and its active metabolite carbamazepine 10,11-epoxide.
    Qu L; Fan Y; Wang W; Ma K; Yin Z
    Talanta; 2016 Sep; 158():77-88. PubMed ID: 27343581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Determination of serum levels of phenobarbital and diphenylhydantoin in the treatment of epilepsy].
    Benetello P; Testa G; Furlanut M
    Clin Ter; 1978 Apr; 85(1):11-8. PubMed ID: 657740
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of serum levels during prolonged combination therapy with phenytoin and phenobarbitone.
    Müller FO; Aucamp AK; Hundt HK; Steyn JM; Olivier LR; Wessels WH
    S Afr Med J; 1977 Aug; 52(9):356-8. PubMed ID: 897947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum concentration of clonazepam and the therapeutic effect of the drug.
    Lambie DG; Johnson RH
    Acta Neurol Scand; 1983 Feb; 67(2):97-102. PubMed ID: 6845979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentration of antiepileptic drugs in persons with epilepsy: a comparative study in serum and saliva.
    Dwivedi R; Singh M; Kaleekal T; Gupta YK; Tripathi M
    Int J Neurosci; 2016 Nov; 126(11):972-8. PubMed ID: 26441313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy.
    Nikolaos T; Stylianos G; Chryssoula N; Irini P; Christos M; Dimitrios T; Konstantinos P; Antonis T
    Med Sci Monit; 2004 Apr; 10(4):MT50-2. PubMed ID: 15039653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monotherapy or polytherapy for epilepsy?
    Reynolds EH; Shorvon SD
    Epilepsia; 1981 Feb; 22(1):1-10. PubMed ID: 6781884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative trial of valproate sodium and clonazepam in chronic epilepsy.
    Shakir RA; Nanda RN; Lambie DG; Johnson RH
    Arch Neurol; 1979 May; 36(5):301-4. PubMed ID: 375883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma level and effect of carbamazepine in grand mal and psychomotor epilepsy.
    Dam M; Jensen A; Christiansen J
    Acta Neurol Scand Suppl; 1975; 60():33-8. PubMed ID: 811075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minor additive inducing effects of phenobarbital on carbamazepine clearance in patients on combined carbamazepine-phenytoin therapy.
    Tomson T; Spina E; Wedlund JE
    Ther Drug Monit; 1987; 9(1):117-9. PubMed ID: 3576657
    [No Abstract]   [Full Text] [Related]  

  • 39. The relationship between the serum levels of phenobarbital and diphenylhydantoin and clinical data in patients with drug resistant epilepsy.
    Bendarzewska-Nawrocka B; Pietruszewska E; Bacia T
    Monogr Neural Sci; 1980; 5():229-34. PubMed ID: 7322157
    [No Abstract]   [Full Text] [Related]  

  • 40. Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.
    Yukawa E
    Clin Pharmacokinet; 1996 Aug; 31(2):120-30. PubMed ID: 8853934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.